title: A potential new therapeutic option for patients with advanced EGFR mutation-positive non-small cell lung cancer in first-line setting.
authors.affiliation: Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.
authors.forename: Cesare
authors.initials: C
authors.lastname: Gridelli
authors.affiliation: Department of Experimental Medicine, University "Sapienza", Rome, Italy.
authors.forename: Tania
authors.initials: T
authors.lastname: Losanno